ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy

Yazar: Okamura, Ryosuke, Kato, Shumei, Lee, Suzanna, Jimenez, Rebecca E, Sicklick, Jason K, Kurzrock, Razelle
Yayımlandı J Immunother Cancer (2020)

Targeting G(1)/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor–based regimens

Yazar: Kato, Shumei, Okamura, Ryosuke, Adashek, Jacob J., Khalid, Noor, Lee, Suzanna, Nguyen, Van, Sicklick, Jason K., Kurzrock, Razelle
Yayımlandı JCI Insight (2021)

High prevalence of clonal hematopoiesis‐type genomic abnormalities in cell‐free DNA in invasive gliomas after treatment

Yazar: Okamura, Ryosuke, Piccioni, David E., Boichard, Amélie, Lee, Suzanna, Jimenez, Rebecca E., Sicklick, Jason K., Kato, Shumei, Kurzrock, Razelle
Yayımlandı Int J Cancer (2021)

Glycosyltransferase and sulfotransferase gene expression profiles in human monocytes, dendritic cells and macrophages

Yazar: Trottein, François, Schaffer, Lana, Ivanov, Stoyan, Paget, Christophe, Vendeville, Catherine, Groux-Degroote, Sophie, Lee, Suzanna, Krzewinski-Recchi, Marie-Ange, Head, Steven R, Gosset, Philippe, Delannoy, Philippe
Baskı/Yayın Bilgisi 2009

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity

Yazar: Kato, Shumei, Okamura, Ryosuke, Kumaki, Yuichi, Ikeda, Sadakatsu, Nikanjam, Mina, Eskander, Ramez, Goodman, Aaron, Lee, Suzanna, Glenn, Sean T., Dressman, Devin, Papanicolau-Sengos, Antonios, Lenzo, Felicia L., Morrison, Carl, Kurzrock, Razelle
Yayımlandı Oncoimmunology (2020)

High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers

Yazar: Riviere, Paul, Goodman, Aaron M, Okamura, Ryosuke, Barkauskas, Donald A., Whitchurch, Theresa J, Lee, Suzanna, Khalid, Noor, Collier, Rachel, Mareboina, Manvita, Frampton, Garrett M., Fabrizio, David, Sharabi, Andrew B., Kato, Shumei, Kurzrock, Razelle
Yayımlandı Mol Cancer Ther (2020)

Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignanci...

Yazar: Kato, Shumei, Okamura, Ryosuke, Mareboina, Manvita, Lee, Suzanna, Goodman, Aaron, Patel, Sandip P., Fanta, Paul T., Schwab, Richard B., Vu, Peter, Raymond, Victoria M., Lanman, Richard B., Sicklick, Jason K., Lippman, Scott M., Kurzrock, Razelle
Yayımlandı JCO Precis Oncol (2019)

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Yazar: Kato, Shumei, Kim, Ki Hwan, Lim, Hyo Jeong, Boichard, Amelie, Nikanjam, Mina, Weihe, Elizabeth, Kuo, Dennis J., Eskander, Ramez N., Goodman, Aaron, Galanina, Natalie, Fanta, Paul T., Schwab, Richard B., Shatsky, Rebecca, Plaxe, Steven C., Sharabi, Andrew, Stites, Edward, Adashek, Jacob J., Okamura, Ryosuke, Lee, Suzanna, Lippman, Scott M., Sicklick, Jason K., Kurzrock, Razelle
Yayımlandı Nat Commun (2020)